277 related articles for article (PubMed ID: 25128513)
21. The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
Tada Y; Ono N; Suematsu R; Tashiro S; Sadanaga Y; Tokuda Y; Ono Y; Nakao Y; Maruyama A; Ohta A; Koarada S
BMC Musculoskelet Disord; 2016 Jul; 17():290. PubMed ID: 27421886
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineage.
Richez C; Barnetche T; Khoryati L; Duffau P; Kostine M; Contin-Bordes C; Blanco P; Schaeverbeke T
J Rheumatol; 2012 Jun; 39(6):1192-7. PubMed ID: 22467922
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis.
Iwamoto N; Fukui S; Umeda M; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nonaka F; Okada A; Koga T; Kawashiri SY; Fujikawa K; Aramaki T; Ichinose K; Hirai Y; Tamai M; Nakamura H; Terada K; Nakashima M; Mizokami A; Origuchi T; Eguchi K; Ueki Y; Kawakami A
Mod Rheumatol; 2016 Sep; 26(5):662-6. PubMed ID: 26708444
[TBL] [Abstract][Full Text] [Related]
24. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
25. Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
Kojima T; Yabe Y; Kaneko A; Takahashi N; Funahashi K; Kato D; Hanabayashi M; Asai S; Hirabara S; Asai N; Hirano Y; Hayashi M; Miyake H; Kojima M; Ishiguro N
Rheumatology (Oxford); 2015 Jan; 54(1):113-20. PubMed ID: 25102861
[TBL] [Abstract][Full Text] [Related]
26. High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
Daïen CI; Gailhac S; Audo R; Mura T; Hahne M; Combe B; Morel J
Rheumatology (Oxford); 2015 Apr; 54(4):601-8. PubMed ID: 25231180
[TBL] [Abstract][Full Text] [Related]
27. A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis.
Saito S; Suzuki K; Yoshimoto K; Kaneko Y; Matsumoto Y; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Oct; 19(1):231. PubMed ID: 29041951
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
[TBL] [Abstract][Full Text] [Related]
29. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
30. Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.
Lee SJ; Park W; Park SH; Shim SC; Baek HJ; Yoo DH; Kim HA; Lee SK; Leee YJ; Park YE; Cha HS; Park JK; Lee EY; Lee EB; Song YW
J Immunol Res; 2015; 2015():487230. PubMed ID: 25922848
[TBL] [Abstract][Full Text] [Related]
31. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
Daïen CI; Fesler P; du Cailar G; Daïen V; Mura T; Dupuy AM; Cristol JP; Ribstein J; Combe B; Morel J
Ann Rheum Dis; 2013 Jun; 72(6):881-7. PubMed ID: 22872022
[TBL] [Abstract][Full Text] [Related]
32. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
Garnero P; Thompson E; Woodworth T; Smolen JS
Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging.
Giles JT; Malayeri AA; Fernandes V; Post W; Blumenthal RS; Bluemke D; Vogel-Claussen J; Szklo M; Petri M; Gelber AC; Brumback L; Lima J; Bathon JM
Arthritis Rheum; 2010 Apr; 62(4):940-51. PubMed ID: 20131277
[TBL] [Abstract][Full Text] [Related]
34. Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients.
Ferraz-Amaro I; Hernández-Hernández MV; Tejera-Segura B; Delgado-Frías E; Macía-Díaz M; Machado JD; Diaz-González F
Horm Metab Res; 2019 Mar; 51(3):200-209. PubMed ID: 30695794
[TBL] [Abstract][Full Text] [Related]
35. Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
Fortunet C; Pers YM; Lambert J; Godfrin-Valnet M; Constant E; Devilliers H; Gaudin P; Jorgensen C; Prades BP; Wendling D; Maillefert JF
Rheumatology (Oxford); 2015 Apr; 54(4):672-7. PubMed ID: 25246640
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
Smolen JS; Aletaha D
Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
[TBL] [Abstract][Full Text] [Related]
37. Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.
Midtbø H; Semb AG; Matre K; Kvien TK; Gerdts E
Ann Rheum Dis; 2017 Feb; 76(2):371-376. PubMed ID: 27269296
[TBL] [Abstract][Full Text] [Related]
38. Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis.
Aguilar-Lozano L; Castillo-Ortiz JD; Vargas-Serafin C; Morales-Torres J; Sanchez-Ortiz A; Sandoval-Castro C; Padilla-Ibarra J; Hernandez-Cuevas C; Ramos-Remus C
J Rheumatol; 2013 Jul; 40(7):1069-73. PubMed ID: 23729804
[TBL] [Abstract][Full Text] [Related]
39. Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.
Cacciapaglia F; Anelli MG; Rinaldi A; Fornaro M; Lopalco G; Scioscia C; Lapadula G; Iannone F
Mediators Inflamm; 2018; 2018():2453265. PubMed ID: 30405318
[TBL] [Abstract][Full Text] [Related]
40. Disease activity and left ventricular structure in patients with rheumatoid arthritis.
Midtbø H; Gerdts E; Kvien TK; Olsen IC; Hirth A; Davidsen ES; Semb AG
Rheumatology (Oxford); 2015 Mar; 54(3):511-9. PubMed ID: 25224414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
